Targeting Metabolic Dependencies in Acute Myeloid Leukemia: A Dual Strategy using Arsenic Trioxide and Artesunate.
Nithya Balasundaram, Arvind Venkatraman, Yolanda Sydney Augustin, Hamenth Kumar Palani, Clément Regnault, Anu Korula, Uday Prakash Kulkarni, Eunice Sindhuvi Edison, Poonkuzhali Balasubramanian, Biju George, Aby Abraham, Sanjeev Krishna, Vikram Mathews
This study investigates the combination of artesunate and arsenic trioxide to treat AML with reduced off-target effects on normal hematopoietic stem cells.
bioRxiv · Jun 23, 2024 · PreprintCancer Biology